B

Bavarian Nordic A/S
CSE:BAVA

Watchlist Manager
Bavarian Nordic A/S
CSE:BAVA
Watchlist
Price: 175.6 DKK 1.04%
Market Cap: 13.8B DKK

Relative Value

The Relative Value of one BAVA stock under the Base Case scenario is 206.61 DKK. Compared to the current market price of 175.6 DKK, Bavarian Nordic A/S is Undervalued by 15%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BAVA Relative Value
Base Case
206.61 DKK
Undervaluation 15%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
76
Median 3Y
2.6
Median 5Y
5.2
Industry
7.2
Forward
2.1
vs History
50
vs Industry
9
Median 3Y
11.2
Median 5Y
10.3
Industry
23.2
Forward
10
vs History
33
vs Industry
14
Median 3Y
9.6
Median 5Y
10.6
Industry
19.3
vs History
vs Industry
3
Median 3Y
-8.4
Median 5Y
-12.3
Industry
22.5
vs History
85
vs Industry
58
Median 3Y
1.4
Median 5Y
1.9
Industry
2.7
vs History
79
vs Industry
68
Median 3Y
2.2
Median 5Y
5.1
Industry
7.5
Forward
1.9
vs History
73
vs Industry
62
Median 3Y
4.2
Median 5Y
10.7
Industry
9.4
vs History
58
vs Industry
13
Median 3Y
6.2
Median 5Y
8
Industry
4.6
Forward
6
vs History
42
vs Industry
10
Median 3Y
8.5
Median 5Y
8.4
Industry
4.5
Forward
8.5
vs History
33
vs Industry
15
Median 3Y
8.4
Median 5Y
9.3
Industry
4.9
vs History
vs Industry
3
Median 3Y
-10.4
Median 5Y
-11.7
Industry
3.7
vs History
79
vs Industry
57
Median 3Y
1.2
Median 5Y
1.5
Industry
4.9

Multiples Across Competitors

BAVA Competitors Multiples
Bavarian Nordic A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Bavarian Nordic A/S
CSE:BAVA
13.7B DKK 2.2 10.4 6.2 9.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 456 664.7 -163 767.4 -198 865.9 -196 596.6
US
Abbvie Inc
NYSE:ABBV
327.6B USD 5.7 78.9 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
155.7B USD 4.6 26.2 14.2 23.3
US
Gilead Sciences Inc
NASDAQ:GILD
134.5B USD 4.7 22.5 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 10.4 -116.5 24.7 25.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 044.6 -521.7 -568.1 -553
AU
CSL Ltd
ASX:CSL
116.4B AUD 5 27.5 17 21.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.6B USD 3.9 12.4 11 12.3
US
Seagen Inc
F:SGT
39.3B EUR 19.7 -60.4 -65.1 -58.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.7B USD 17.3 -150.9 -676.2 -338.8
P/E Multiple
Earnings Growth PEG
DK
B
Bavarian Nordic A/S
CSE:BAVA
Average P/E: 29.6
10.4
0%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -163 767.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -116.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.7 N/A N/A
AU
CSL Ltd
ASX:CSL
27.5
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.4 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -150.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
B
Bavarian Nordic A/S
CSE:BAVA
Average EV/EBITDA: 14
6.2
4%
1.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 865.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -568.1 N/A N/A
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -676.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
B
Bavarian Nordic A/S
CSE:BAVA
Average EV/EBIT: 18.3
9.3
8%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 596.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.3
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -553 N/A N/A
AU
CSL Ltd
ASX:CSL
21.2
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.3
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -338.8 N/A N/A